Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05708859
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose health services research
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT05708859
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT05708859. Randomized; quadruple masking; primary purpose health services research. Start 2024-01-02 (actual); primary completion 2025-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Acronym
- T-PLAQUE
- Condition
- Type II Diabetes
- Condition
- Atherosclerosis
- Intervention (Drug)
- Tirzepatide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Matthew J. Budoff
- Collaborator
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct05708859- Content hash
188165d60c60b8dfa0c5d3bac981a8ade907e074f4314ba99084b4bd09674200